Abstract:Objective To analyze the therapeutic efficacy of intensive immunosuppressive therapy(IST) in children with severe aplastic anemia(SAA) and compared it with only cyclosporine A(CSA) therapy,and evaluate the relation between granulocyte colony stimulating factor (G-CSF) reaction and therapeutic efficacy before intensive immunosuppressive therapy. Methods The study cohort consisted of 68 consecutive patients diagnosed as severe aplastic anemia in the Department of Pediatrics,Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University between January 2000 and November 2007. Fifty-five cases of 68 patients accepted intensive immunosuppressive group (IST group),while other 13 cases received only cyclosporine A (CSA group) because of poor economy. The different therapeutic efficacy of these two regimens was analyzed. The procedure of this study was consistent with ethical standard established by the committee of investigation in human beings of Sun Yat-Sen Memorial Hospital,Sun Yat-Sen University,and it was approved by this committee. Informed consent was obtained from all participates.24 cases of severeaplastic anemia received granulocyte colony stimulating factor as experimental treatment before intensive immunosuppressive therapy according to the degree of peripheral blood count's response to granulocyte colony stimulating factor. These 24 cases were divided into reaction sub-IST group ( n =13)and non-reaction sub-IST group.( n =11). The differences of therapeutic efficacy at the end of 6 months after treatment and long-term effects were observed. Results The average effective time of IST group and CSA group after treatment were 3.4 months(1~13 months) and 4.5 months (1~15 months),respectively. The efficacy rates of IST group and CSA group at the end of 1st,3rd,6th,9th and 12th months after treatment were 70.9%,58.2%,79.5%,87.2% and 89.7% vs. 46.2%,38.5%,46.2%,61.5% and 61.5%,respectively. More than 1 year follow-up of 39 patients in IST group,the total efficacy rate was 89.7%(35/39). More than 1 year follow-up of 13 patients in CSA group,the total efficacy rate was 61.5%(8/13). There had statistically significant difference between two groups(χ 2=5.419,P 0.05). The efficacy rates of reaction sub-IST group and non-reaction sub-IST group to granulocyte colony stimulating factor at the end of 6th months after treatment were 76.9% and 45.6%,respectively.There had no significant difference between two groups ( P 0.05).The total efficacy rates of reaction sub-IST group and non-reaction sub-IST group to granulocyte colony stimulating factor were 92.3%,(12/13)and 54.5%(6/11),respectively.The former was significant higher than that of the latter. There was statistically significant difference in these two groups( P 0.05). The efficacy of intensive immunosuppressive therapy was better than that of single-use cyclosporine A. The average effective time of IST group and CSA group after treatment were 3.4 months and 4.5 months,respectively. The efficacy of IST group and CSA group at 1 year after treatment were 89.7% and 61.5%,respectively. The total efficacy rate of reaction sub-IST group and non-reaction sub-IST group to granulocyte colony stimulating factor were 92.3% and 54.5%,respectively. Conclusion The therapeutic efficacy of intensive immunosuppressive therapy in children with severe aplastic anemia is better than that of cyclosporine A therapy only. Children with severe aplastic anemia who responded well to granulocyte colony stimulating factor had a better prognosis in the intensive immunosuppressive therapy.

Efficacy of cyclosporine A on treatment of 126 children with non-severe aplastic anemia

Analysis of the Outcome and Prognostic Factors of Cyclosporine A in Children with Non-severe Aplastic Anemia

Cyclosporine Monotherapy in Pediatric Patients With Non-severe Aplastic Anemia: A Retrospective Analysis

[Immunosuppressive therapy for 54 children patients with acquired severe aplastic anemia].

Evaluation of the efficacy of immunosuppressive treatments with antithymocyteglobin combined with cyclosporine A(CSA) in children with acquired very severe aplastic anemia

[The Outcome of Severe Aplastic Anemia Children Treated with Reduced Dose of Cyclophosphamide Combined Cyclosporine A].

Effect of Cyclosporin A in the Treatment of Aplastic Anemia in Children

Outcome of a novel immunosuppressive strategy of cyclosporine, levamisole and danazol for severe aplastic anemia

Clinical Analysis of the Efficacy of Intensive Immunosuppressive Therapy in 68 Children with Severe Aplastic Anemia

Effectiveness of Immunosuppressive Therapy for Childhood Aplastic Anemia and Its Predictive Factors

[Efficacy of immunosuppressive therapy in children with acquired aplastic anemia]

Treatment of aplastic anemia with intensive immunosuppressive agents in children

The efficacy and safety of cyclosporine A plus androgen versus androgen alone for adult patients with non-severe aplastic anemia in China: a meta-analysis of randomized controlled trials

Response to Single Agent Cyclosporin in Patients with Non-Severe Aplastic Anaemia

Cyclosporine Therapy in Patients with Transfusion-independent Non-severe Aplastic Anemia: A Retrospective Analysis

Clinical analysis of immunosuppressive therapy in childhood aplastic anemia

Influential factors of response to childhood aplastic anemia treated with antithymocyte globulin and Cyclosporin A

A promising immunosuppressive strategy of cyclosporine alternately combined with levamisole is highly effective for moderate aplastic anemia

Cyclosporin A in Combination with Androgens for Treating 56 Patients with Aplastic Anemia

Efficacy and Safety of Combined Immunosuppressive Therapy Plus Umbilical Cord Blood Infusion in Severe Aplastic Anemia Patients: A Cohort Study

Allogeneic Hematopoietic Stem Cell Transplantation Therapy on Severe Aplastic Anemia in Children